Shifamed’s Adona Medical unveils next-gen heart failure management platform
Shifamed portfolio company Adona Medical today announced the introduction of its next-generation heart failure platform.
Related Articles
WeightWatchers partners with Personify Health for B2B weight loss
The announcement comes less than a year after Virgin Pulse and HealthComp announced their $3 billion merger and their rebranding as Personify Health.
Medtronic renal denervation system wins approval in China
Medtronic today announced its Symplicity Spyral renal denervation system won National Medical Products Administration approval in China.
Research Shows Generative AI In The EHR Can Work Well, But Only With Human Oversight – MedCity News
Mass General Brigham researchers conducted a study to learn more about the efficacy of large language models when used to draft responses to patient messages…
The race for healthcare AI models heats up as Google’s Med-Gemini surpasses GPT-4
Google and DeepMind released an open access paper on their newest artificial intelligence tools intended for use in hea | Results released by Google on…
newsGP – Lung cancer added to national screening register
Eligible Australians could soon be offered a scan every two years in a bid to bolster early detection, but the RACGP says the register needs…
Five ways AI-powered startups are changing healthcare in Kenya
Access to healthcare services, particularly for vulnerable populations such as people with disabilities, has always been a challenge.
KKR To Buy India’s Medical Devices Firm Healthium Medtech From Apax Partners
KKR has agreed to acquire Bengaluru-based medical devices company Healthium Medtech from an affiliate of funds advised by Apax Partners LLP.
“EzeRx is contemplating IPO launch as part of the future endeavours”
“EzeRx is contemplating an IPO launch as part of the future endeavours”
Amae Health is building an in-person approach to mental healthcare in an increasingly digital space | TechCrunch
While many recent mental health-focused startups are digital first, Amae Health focuses on the importance of in-person care.
Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds – MedCity News
Amgen is confident its injectable obesity drug would have a differentiated profile compared to medications now on the market from Novo Nordisk and Eli Lilly…